Zhongnan Medical Journal Press

Home Results

A total of 2167 result was found. Results that relate to R

Efficacy and safety of tegoprazan in the treatment of gastroesophageal reflux disease: a systematic review and Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1294-1301.
3959 times 793 times

LU Ronghua LIU Jiaojiao PANG Tengfei CAI Rui YUAN Jian

Tegoprazan Gastroesophageal reflux disease Meta-analysis Systematic review Randomized controlled trial
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1302-1310.
2871 times 534 times

YANG Shou NIE Ying GONG Yuan KANG Shuo HOU Yibing WANG Xiaohui PAN Zhenhua

Toripalimab Advanced esophageal cancer Rapid health technology assessment Effectiveness Safety Economy
Details
Rapid health technology assessment of avatrombopag for the treatment of primary immune thrombocytopenia in adults

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1311-1319.
3095 times 560 times

LI Zhou LING Ya ZHANG Jie ZHU Ling

Avatrombopag Primary immune thrombocytopenia Efficacy Safety Economy Rapid health technology assessment
Details
Research advances in adverse drug reactions and their management in targeted therapy for driver gene-positive advanced non-small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1320-1329.
3302 times 566 times

FAN Jiameng PAN Lei

Non-small cell lung cancer Target therapy Adverse drug reactions Symptom management Biomarker
Details
Pharmaceutical care for a case of abemaciclib-induced interstitial lung disease

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1330-1334.
2842 times 555 times

DING Liping WU Wei WANG Chunhui

Abemaciclib Interstitial lung disease Breast cancer Pharmaceutical care
Details
Pharmaceutical practice of bevacizumab-induced refractory hypertension and proteinuria in a patient with advanced lung adenocarcinoma

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1335-1339.
2976 times 532 times

YAN Jiaju YUAN Yongyong LIU Meng

Bevacizumab Lung adenocarcinoma Resistant hypertension Proteinuria Phamaceutical care
Details
Anti-infection treatment and pharmaceutical care for a patient with liver cirrhosis complicated with severe psittacosis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1340-1346.
3080 times 569 times

XING Baiqian LIU Hunan SUN Yihong LU Nianfang LI Zhongdong

Liver cirrhosis Chlamydia psittaci Omadacycline Voriconazole Posaconazole Pharmaceutical care
Details
Acute drug-induced liver injury associated with tolvaptan in a patient with cardiac amyloidosis: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(11):1347-1352.
3006 times 529 times

YAO Tingyi ZHANG Weixia

Tolvaptan Drug-induced liver injury AL cardiac amyloidosis Heart failure
Details
Investigation and implementation exploration on knowledge, attitude and practice of influenza vaccination among college students

Published on New Medicine 2025,35(11):1249-1255.
4282 times 721 times

XUE Lijia NIE Ying WANG Wei WANG Lu LIU Hongjun LUO Shihuan LI Nan ZOU Xinyu LI Sheyu LUO Li

Influenza Vaccination College students Knowledge attitude and practice Influencing factors
Details
Association of sleep duration and sleep quality with metabolic associated fatty liver disease among Wuhan subway workers

Published on New Medicine 2025,35(11):1256-1264.
3969 times 608 times

PENG Rong LIU Junling SHI Bin TAO Yi YAN Xueping HE Zhenyu

Sleep duration Sleep quality Metabolic associated fatty liver disease Mediation effect
Details
Research on the awareness and needs of scientific and technological achievements transformation in tertiary public hospitals in Shanghai

Published on New Medicine 2025,35(11):1265-1271.
4280 times 636 times

SUN Lu LI Huiyi SHAN Qiyuan ZHANG Xinyi XU Zengguang

Tertiary public hospitals Technology transfer Transfer awareness Transfer demand Patent transformation
Details
Prediction and analysis of red blood cells clinical demand based on the ARIMA model

Published on New Medicine 2025,35(11):1272-1278.
3923 times 579 times

YANG Xu LIU Shuqi HUANG Hui CHEN Xiulan LOU Yiling CAO Shiyi JIANG Qingqing

Red blood cell ARIMA multiplicative seasonal model Demand forecasting Health management
Details
The distribution of RhCE phenotypes and molecular genetic background of D variants in preliminary screening of RhD-negative blood donors

Published on New Medicine 2025,35(11):1279-1285.
3884 times 577 times

ZHANG Xia ZHAO Gaowei FENG Zhihui GUO Ming

RhD negative RhCE phenotype D variant
Details
Construction and validation of a prediction model for postmenopausal asymptomatic endometrial thickening

Published on New Medicine 2025,35(11):1286-1293.
4633 times 565 times

XU Yan YANG Tingting MA Chenglei ZHAO Fang MA Xin

Endometrial thickening Risk factors Nomogram Predictive model
Details
Assessment of current status and influencing factors of financial toxicity among elderly hypertensive patients in rural Zhuzhou

Published on New Medicine 2025,35(11):1294-1302.
3905 times 584 times

ZHANG Zhen WEI Shiyi TIAN Yanzhen WU Yanxian WANG Lang ZHANG Shiji FENG Nina

Elderly hypertension Financial toxicity Self-management behavior Influencing factors Random forest model
Details